CALC
CalciMedica, Inc. Common Stock
NASDAQ: CALC · HEALTHCARE · BIOTECHNOLOGY
$0.62
+3.47% today
Updated 2026-05-06
Market cap
$9.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.98
Dividend yield
—
52W range
$0 – $7
Volume
0.3M
CalciMedica, Inc. Common Stock (CALC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — |
| Cost of revenue | $175000.00 | $303000.00 | $395000.00 | $519000.00 | $52000.00 | $58000.00 | $58000.00 | $46000.00 |
| Gross profit | $-175000.00 | $-303000.00 | $-395000.00 | $-519000.00 | $-52000.00 | $-58000.00 | $-58000.00 | $-46000.00 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $22.97M | $30.58M | $20.96M | $18.90M | $8.35M | $15.86M | $14.48M | $15.23M |
| SG&A | $5.60M | $6.92M | $8.87M | $17.04M | $5.84M | $22.22M | $9.73M | $7.89M |
| Operating income | $-28.57M | $-37.50M | $-29.83M | $-35.95M | $-14.19M | $-38.08M | $-24.20M | $-23.12M |
| Operating margin | — | — | — | — | — | — | — | — |
| EBITDA | $-28.20M | $-36.73M | $-29.44M | $-35.43M | $-7.64M | $-38.02M | $-24.15M | $-23.12M |
| EBITDA margin | — | — | — | — | — | — | — | — |
| EBIT | $-28.38M | $-37.04M | $-29.83M | $-35.95M | $-7.69M | $-38.08M | $-24.20M | $-23.17M |
| Interest expense | — | — | $143000.00 | $126000.00 | $132000.00 | $110000.00 | $0.00 | $1.42M |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-28.38M | $-37.04M | $-27.53M | $-35.82M | $-7.82M | $-34.36M | $-13.70M | $-29.56M |
| Net income growth (YoY) | — | -30.5% | +25.7% | -30.1% | +78.2% | -339.1% | +60.1% | -115.8% |
| Profit margin | — | — | — | — | — | — | — | — |